EDG3 antagonists (Toa Eiyo)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameEDG3 antagonists (Toa Eiyo)
Drug Alias Nameendothelial differentation gene 3 antagonists (Toa Eiyo)sphingosine 1 phosphate antagonists (Toa Eiyo)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-phosphate receptor 3 inhibitors
TargetsSphingosine 1-phosphate receptor 3
Therapy Area/IndicationsAngiogenesis disorderCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesToa Eiyo Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesToa Eiyo Ltd
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorderCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A